Oncotarget
Press Release: New Oncology-Focused Papers Published in Volume 13
Jun 23, 2022
Explore diverse research papers in Oncotarget Volume 13 focusing on topics like PARP inhibitors, immunotherapy, colorectal cancer, DNA breaks on memory, and nanobiotechnology for targeted therapy. Discover advancements in bladder, breast, and colorectal cancers, genetic influences on cytotoxicity, glucocorticoid receptor therapy for cancer, endometrial cancer cell growth, gene-driven endocrine resistance, treatment combinations for glioblastoma, and immunotherapy responses in specific mutations.
15:26
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Volume 13 of Oncotarget features 64 high-impact oncology-focused papers by prestigious researchers worldwide.
- Topics in Volume 13 cover PARP inhibitor combination therapy efficacy and novel drug targets for bladder cancer.
Deep dives
Oncotearget's Volume 13 and Research Topics
Oncotearget's Volume 13 includes 64 high-impact oncology-focused papers authored by prestigious researchers worldwide. Select papers in this volume are part of special collections on breast and lung cancer research. Topics covered include the efficacy of PARP inhibitor combination therapy, mechanisms of hyperprogression and immunotherapy, and the impact of nutrition on survival in gastric cancer patients.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
